Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
SERUM 7 AB
AB
Active
Org 5590989991
Lissvägen 3 A, 791 74
Falun
Post-secondary non-tertiary education
· NACE 8533
Est. 2017
0 employees
Watchlist
Share
Sweden
/
Companies
/
Post-secondary non-tertiary education
/
SERUM 7 AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
344
120
0
0
0
Staff expenses
—
−0
−17
−0
−0
EBITDA
160
25
−188
−101
−52
Depreciation & amort.
−0
—
—
−60
−60
EBIT
160
25
−188
−161
−112
Net financials
−1
−1
−1
0
0
Profit before tax
151
47
−49
1
−95
Tax
−34
−11
1
—
—
Net profit
117
36
−48
1
−95
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 478
1 497
1 274
1 156
1 069
Equity
1 122
1 158
1 110
1 111
1 016
Long-term debt
0
—
—
—
—
Short-term debt
15
20
−15
27
53
Total debt
15
20
−15
27
53
Financial ratios
5-year trend
EBITDA-margin
-5246100.0%
This company
15.8%
Market median
-33203265% vs market
2020
2024
Soliditetsgrad
95.1%
This company
38.2%
Market median
+149% vs market
2020
2024
Egenkapitalforrentning
-9.4%
This company
18.4%
Market median
-151% vs market
2020
2024
Nettoresultatgrad
-9512000.0%
This company
8.1%
Market median
-117432199% vs market
2020
2024
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Gæld/egenkapital
0.05×
This company
0.62×
Market median
+92% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on SERUM 7 AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
